Clinical Trial Update: A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating safety, tolerability, and immunogenicity of a recombinant Hepatitis B vaccine with an upgraded production process (V232-054) has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Recombivax HB (Hepatitis B vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B Infection | Phase 3 | Status: COMPLETED